RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE

STABILIZED CORONAVIRUS SPIKE PROTEIN FUSION PROTEINS

MODIFIED VIRUS-LIKE PARTICLES OF BACTERIOPHAGE AP205

MODIFIED CHIMERIC CORONAVIRUS SPIKE PROTEIN FOR ENHANCEMENT OF VIRAL TITERS

EXTENDED-RANGE SPRAY APPLICATOR

SARS-COV-2 VACCINE COMPOSITION AND USE THEREOF

TRANSDERMAL ACTIVE AGENT DELIVERY DEVICES HAVING CORONAVIRUS VACCINE COATED MICRO-PROTRUSIONS

DEVELOPMENT OF COVID-19 VACCINE USING A DUAL TLR LIGAND LIPOSOME ADJUVANT

ADJUVANTED MUCOSAL SUBUNIT VACCINES FOR PREVENTING SARS-COV-2 TRANSMISSION AND INFECTION

FOLD PROMOTERS AND THEIR USE FOR THE PRODUCTION AND STABILIZATION OF POLYPEPTIDES

CORONAVIRUS VACCINE FORMULATIONS

METHOD FOR INDUCING CELLULAR IMMUNITY TO INFECTION BY SARS-CoV-2

OPTIMAL PRODUCTION OF SARS-COV-2 VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN MAMMALIAN CELLS

Nucleic acid base vaccine against emerging SARS-CoV-2 variants

MICROORGANISM DISPLAYING ANTIGENIC PROTEIN OF THE SARS-CoV2 CORONAVIRUS

CANCER VACCINE AND METHOD OF USE THEREOF

STABILIZED CORONAVIRUS SPIKE (S) PROTEIN IMMUNOGENS AND RELATED VACCINES

VARIANT STRAIN-BASED CORONAVIRUS VACCINES

Interferon-producing universal sarbecovirus vaccines, and uses thereof

IMMUNOGENIC COMPOSITIONS

Vaccines and Antibodies for the Treatment and Prevention of Microbial Infections

COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES

Coronavirus vaccine compositions and methods

VARIANT STRAIN-BASED CORONAVIRUS VACCINES

REVERSE GENETICS-BASED COMPOSITIONS OF RECOMBINANT SARS-COV-2

VACCINE FORMULATION COMPRISING RECOMBINANT OVERLAPPING PEPTIDES AND NATIVE PROTEINS

Coronavirus vaccine

SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucleocapsid-ETSD immunogens

SARS-CoV-2 mRNA vaccine and preparation method and use thereof

SARS-COV-2 PROTEIN-DERIVED PEPTIDE AND VACCINE CONTAINING SAME

FULLY SYNTHETIC, LONG-CHAIN NUCLEIC ACID FOR VACCINE PRODUCTION TO PROTECT AGAINST CORONAVIRUSES

Adenoviral vector not including replication competent adenovirus, and use thereof

REDUCED FOAMING VACCINE COMPOSITIONS

Coronavirus vaccine

MODIFIED POLYPEPTIDES WITH IMPROVED PROPERTIES

CHIMERIC CORONAVIRUS S PROTEIN COMPOSITIONS AND METHODS OF USE

Coronavirus vaccine

RECOMBINANT VECTORS ENCODING CHIMERIC CORONAVIRUS SPIKE PROTEINS AND USE THEREOF

FUSION PROTEIN AND APPLICATION THEREOF

LNP COMPOSITIONS COMPRISING RNA AND METHODS FOR PREPARING, STORING AND USING THE SAME

Vaccine

PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST AN INFECTION BY SARS-COV-2 (COVID-19)

MICRO-ELECTROPORATION BASED DRUG DELIVERY SYSTEM, METHODS FOR USE AND FABRICATION THEREOF

TEMPERATURE-SENSITIVE BETACORONAVIRUS STRAIN AND VACCINE

RECOMBINANT VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATED METHODS

SAR-COV-2 DNA Vaccine and Method of Administering Thereof

CORONAVIRUS-DERIVED RECEPTOR-BINDING DOMAIN VARIANT HAVING REDUCED ACE2-BINDING AFFINITY AND VACCINE COMPOSITION COMPRISING THE SAME

CIRCULAR RNA VACCINES AND METHODS OF USE THEREOF

PARTICLES, DNA & RNA

IMMUNOGENIC COMPOSITIONS AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2

Coronavirus disease (COVID-19) vaccine

Coronavirus vaccine

SINGLE-CHAIN CORONAVIRUS VIRAL MEMBRANE PROTEIN COMPLEXES

Anti COVID-19 Therapies targeting nucleocapsid and spike proteins

CORONAVIRUS VACCINE FORMULATIONS

Peptides and Combinations of Peptides for Use in Immunotherapy Against an Infection by Sars-COV-2 (COVID-19)

REAGENTS AND METHODS FOR PREVENTING, TREATING OR LIMITING SEVERE ACUTE RESPIRATORY SYNDROME (SARS) CORONAVIRUS INFECTION

AAV5-BASED VACCINE AGAINST SARS-COV-2

RECOMBINANT SARS-COV-2 SPIKE PROTEIN SUBUNITS, EXPRESSION AND USES THEREOF

NUCLEIC ACIDS ENCODING A POLYPEPTIDE COMPRISING A MODIFIED FC REGION OF A HUMAN IGG1 AND AT LEAST ONE HETEROLOGOUS ANTIGEN

METHOD FOR INDUCING IMMUNITY TO SARS-CoV-2

Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein

VARIANT SARS-CoV-2 PROTEINS AND USES THEREOF

CELLULAR VACCINE PLATFORM AND METHODS OF USE

RECOMBINANT VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATED METHODS

CORONAVIRUS VACCINE

EFFICIENT EXPRESSION SYSTEM OF SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD), METHODS FOR PURIFICATION AND USE THEREOF

ENGINEERED CORONAVIRUS SPIKE (S) PROTEIN AND METHODS OF USE THEREOF

IDENTIFICATION OF BIOMIMETIC VIRAL PEPTIDES AND USES THEREOF

REGULATORY T CELL EPITOPES AND DETOLERIZED SARS-COV-2 ANTIGENS

AN IMPROVED MEASLES VIRUS VACCINE VECTOR BASED ON MULTIPLE TANDEM ADDITIONAL TRANSCRIPTION UNITS (ATUS)

RECOMBINANT ENTEROVIRUSES AND USES THEREOF

ANTI- SARS-COV-2-INFECTION PROTEIN AND VACCINE

CORONAVIRUS VACCINE CONSTRUCTS AND METHODS OF MAKING AND USING SAME

RECOMBINANT VACCINE AGAINST COVID-19 BASED ON A PARAMYXOVIRUS VIRAL VECTOR

ENGINEERING CORONAVIRUS SPIKE PROTEINS AS VACCINE ANTIGENS, THEIR DESIGN AND USES

HIGH-POTENCY SARS CORONAVIRUS 2 ANTIGEN AND VACCINE COMPOSITION COMPRISING SAME

RAPID VACCINE PLATFORM

SARS-CoV-2 Vaccines and Antibodies

SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) POLYPEPTIDES AND USES THEREOF FOR VACCINE PURPOSES

VACCINE COMBINATION AGAINST SARS-COV-2 AND METHOD FOR PREVENTING INFECTION OF SARS-COV-2

CHIMERIC ADENOVIRAL VECTORS

ENGINEERING BROADLY REACTIVE CORONAVIRUS VACCINES AND RELATED DESIGNS AND USES

A UNIVERSAL ADOPTIVE IMMUNOTHERAPY APPROACH TO TREAT COVID-19 AND FUTURE EMERGING INFECTIOUS DISEASES

Coronavirus Disease 2019(COVID -19) Recombinant Spike Protein Forming Trimer, Method for Mass Producing Recombinant Spike Protein in Plants, and Method for Preparing Vaccine Composition on Basis Thereof

ADJUVANTS FOR SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS (SARS-COV) VACCINES

Tetanus vaccine platform for embedding COVID-19 vaccine

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

CORONAVIRUS VACCINE COMPOSITIONS AND METHODS OF USE

COMPOSITIONS AND METHODS FOR DETECTING AND TREATING A SARS-COV-2 INFECTION

RECOMBINANT BACTERIA FOR USE AS A VACCINE TO PREVENT COVID19 INFECTION

RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTION, AND METHODS OF USING THE SAME FOR TREATING COVID-19

METHOD AND SYSTEM FOR IDENTIFYING ONE OR MORE CANDIDATE REGIONS OF ONE OR MORE SOURCE PROTEINS THAT ARE PREDICTED TO INSTIGATE AN IMMUNOGENIC RESPONSE, AND METHOD FOR CREATING A VACCINE

DEFECTIVE INTERFERING VIRAL GENOMES

Use of Human Resistin as a Trimerization Partner for Expression of Trimeric Proteins

SARS-COV-2 VIRAL PROTEINS AND USE THEREOF

METHOD FOR IMPROVING ANTIGEN IMMUNOGENICITY, CORONAVIRUS ANTIGEN, USE THEREOF, RECOMBINANT VECTOR, EXPRESSION KIT, TRANSGENIC CELL LINE, RECOMBINANT BACTERIUM, CORONAVIRUS VACCINE, PREPARATION METHOD OF ANTIGEN AND NUCLEOTIDE SEQUENCE

PERSISTENT MEMORY T-CELL RESPONSES TO CANCER AND INFECTIOUS-DISEASE ANTIGENS BY MANIPULATION OF AMINO ACID-CATABOLISM PATHWAYS

SARS-CORONAVIRUS 2 (SARS-COV-2) SUBUNIT VACCINE CANDIDATES

ANTIGENIC DETERMINANTS PROTECTIVE IMMUNITY, SERODIAGNOSTIC AND MULTIVALENT SUBUNITS PRECISION VACCINE AGAINST SARS-CoV-2

Engineering, production and characterization of plant produced Nucleocapsid and Spike structural proteins of SARS CoV 2 as vaccine candidates against COVID19

RECOMBINANT VIRUSES, INSECT CELLS AND THEIR USES IN VIRAL DETECTION AND VACCINATION

MODIFIED GENE VACCINES AGAINST AVIAN CORONAVIRUSES AND METHODS OF USING THE SAME

COVID-19 VACCINE BASED ON THE MYXOMA VIRUS PLATFORM

T CELL EPITOPE CLUSTERS AND RELATED COMPOSITIONS USEFUL IN THE PREVENTION, DIAGNOSIS, AND TREATMENT OF COVID-19

VACCINES FOR CORONAVIRUS AND METHODS OF USING THE SAME

MERS-CoV VACCINE

CORONAVIRUS VACCINES, COMPOSITIONS, AND METHODS RELATED THERETO

ANTIGEN SPECIFIC EPITOPE BASED ANTI-INFECTIVE VACCINES

DEOPTIMIZED SARS-CoV-2 AND METHODS AND USES THEREOF

SARS-COV-2 VACCINE

CORONAVIRUS VACCINES COMPRISING A TLR9 AGONIST

CORONA VIRUS VACCINE

CORONAVIRUS RNA VACCINES

POXVIRUS-BASED VECTORS PRODUCED BY NATURAL OR SYNTHETIC DNA AND USES THEREOF

Coronavirus vaccine compositions, methods, and uses thereof

Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus

CORONAVIRUS VACCINES AND METHODS OF USE

PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION

Systems and methods for the preparation of vaccines utilizing predictably inactivated pathogens

METHOD FOR IMPROVING ANTIGEN IMMUNOGENICITY, CORONAVIRUS ANTIGEN, USE THEREOF, RECOMBINANT VECTOR, EXPRESSION KIT, TRANSGENIC CELL LINE, RECOMBINANT BACTERIUM, CORONAVIRUS VACCINE, PREPARATION METHOD OF ANTIGEN AND NUCLEOTIDE SEQUENCE

Efficient expression system of SARS-CoV-2 receptor binding domain (RBD), methods for purification and use thereof

Coronavirus vaccine

CORONAVIRUS VACCINE FORMULATIONS

Coronavirus disease (COVID-19) vaccine

SECRETABLE PROTEIN INDUCED IMMUNE TOLERIZATION AND TREATMENT OF AUTOIMMUNE, ALLERGIC AND OTHER DISEASES AND DISORDERS

SARS-COV-2 SUBUNIT AND VARIANT VACCINES

MESSENGER RNA THERAPEUTICS AND COMPOSITIONS

Synthetic pDNA vaccines against COVID-19

IMMUNE CELLS FOR ADOPTIVE CELL THERAPIES

MODIFIED SPIKE PROTEIN AND METHOD OF TREATMENT

Vaccine delivery method

NOVEL FISH CORONAVIRUS

VACCINES FOR TREATING SARS INFECTIONS IN CANCER PATIENTS

Paramyxovirus vaccine strain for novel coronavirus pneumonia and construction method thereof

SYNTHETIC PLASMID DNA VACCINE EXPRESSING A CODON-OPTIMIZED SARS-COV-2 SPIKE PROTEIN AND METHODS FOR ITS USE

Synthetic plasmid DNA vaccine expressing a codon-optimized SARS-COV-2 spike protein

RNA constructs and uses thereof

Method of treating or preventing clinical signs caused by infectious bronchitis virus with 4/91 IBV vaccine having heterologous spike protein

RECOMBINANT ADENOVIRUS VACCINE FOR CORONA VIRUS DISEASE 19 AND COMBINATION THERAPY USING THE SAME

RNA CONSTRUCT

AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2 IN LIQUID FORM (VARIANTS)

RNA constructs and uses thereof

Neutralizing antibody immunoassays

Amino acid sequence derived from S protein of SARS-CoV2 for generating an anti-SARS-CoV-2 antibody

REDUCED FOAMING VACCINE COMPOSITIONS

IMMUNOMODULATION PLATFORM AND METHODS OF USE

EXPRESSION VECTOR AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2

PHARMACEUTICAL COMPOSITION CONTAINING STABILIZED NUCLEIC ACID ADJUVANT

PHARMACEUTICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2

VIRAL VACCINES AND METHODS OF FORMING THE SAME

Computational reduction vaccine for Covid-19 originating from Civet Sars, Bat Sars, BetaCov btrs, BetaCov BtRI, and Neoromicia

METHOD FOR RAPID PREPARATION OF EPIDEMIC INFECTIOUS BRONCHITIS VACCINE

ATTENUATED IBV WITH EXTENDED CELL CULTURE AND TISSUE TROPISM

UNIVERSAL BACTERIOPHAGE T4 NANOPARTICLE PLATFORM TO DESIGN MULTIPLEX SARS-COV-2 VACCINE CANDIDATES BY CRISPR ENGINEERING

Vaccine against infectious bronchitis

MULTIVALENT CARRIERS AND RELATED VACCINE COMPOSITIONS

ENGINEERED MRNA SEQUENCES AND USES THEREOF

VIRUS-LIKE PARTICLES

PORCINE EPIDEMIC DIARRHEA (PED) VIRUS VACCINE COMPOSITION AND PREPARATION METHOD THEREOF

Chimeric molecules and uses thereof

Corona virus vaccine formulations

Chimeric protein for coronavirus vaccine

Attenuated isolate of infectious bronchitis virus strain DMV1639

Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom

Recombinant polypeptides containing at least one immunogenic fragment and antibody fc region and uses thereof

Multivalent vaccines for rabies virus and coronaviruses

Compositions and methods for detection and treatment of coronavirus infection

Composition and method of mRNA vaccines against novel coronavirus infection

EMULSOMES COMPRISING S-LAYER FUSION PROTEINS AND METHODS OF USE THEREOF

Prime-boost vaccination regimen

Coronavirus vaccine compositions, methods, and uses thereof

Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses

Bovine rotavirus fusion protein and calf diarrhea multivalent vaccine

Virus like nanoparticle compositions and methods thereof

Computational reduction vaccine for Covid-19 Bin75

Computational reduction vaccine for Covid-19 BIN100

S-LAYER VACCINE FUSION PROTEINS AND METHODS OF USE

MERS-CoV vaccine

Viral vaccines for in vivo expression of a nucleic acid encoding an immunogenic peptide and methods of using the same

CORONAVIRUS VACCINE AND METHODS OF USE THEREOF

Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines

Measles virus vaccine expressing SARS-CoV-2 protein(s)

Coronavirus vaccine

SURFACE DISPLAY OF PROTEINS ON RECOMBINANT BACTERIA AND USES THEREOF

Method of Vaccination for SARS Virus

Stabilizing Mutants of Prefusion Sars-Cov-2 (Covid-19) Spike Protein And Improved Yeast Surface Display Engineering Platform For The Same

Immunogenic composition and use thereof

Vaccine compositions for the treatment of coronavirus

Apparatus for releasably holding a socket

Adjuvant compositions

Composite multi-epitope expression cassette, a recombinant virus composed thereof and application thereof

CoV-2 (CoV-n) antibody neutralizing and CTL vaccines using protein scaffolds and molecular evolution

PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION

ORAL VACCINES EXPRESSED IN YEAST FOR COVID-19

Alphavirus replicon encoding chimeric SARS-CoV-2 receptor binding domains

Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Coronavirus vaccine compositions and methods

Compositions and methods for inducing immune responses

Replication-defective adenoviruses comprising nucleic acids encoding SARS-CoV-2 s glycoprotein and modified N protein comprising an endosomal targeting sequence

Prefusion coronavirus spike proteins and their use

Vaccines against coronavirus and methods of use

NOVEL PEPTIDES FOR VACCINATION AND TREATMENT OF 2019-nCoV INFECTIONS

Coronaviruses epitope-based vaccines

Zoonotic disease RNA vaccines

Human Betacoronavirus Lineage C and Identification of N-Terminal Dipeptidyl Peptidase As Its Virus Receptor

Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines

THERAPEUTIC COMBINATIONS OF DRUGS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION

USE OF BETA-GLUCAN EXTRACT IN IMMUNOPOTENTIATION OF AN AVIAN ANIMAL

Coronavirus vaccine formulations

Coronavirus vaccine formulations

Self-assembling insect ferritin nanoparticles

Extended-range spray applicator

Stabilized coronavirus spike (S) protein immunogens and related vaccines

Antigen-surface-coupled liposome vaccine for non-human animals

Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen

Live attenuated Arkansas serotype infectious bronchitis virus vaccine

Vaccine composition and method of preventing porcine epidemic diarrhea virus infection in swine

Vaccine delivery method

Stabilized coronavirus spike (S) protein immunogens and related vaccines

Combination HMPV/RSV RNA vaccines

NSP10 self-assembling fusion proteins for vaccines, therapeutics, diagnostics and other nanomaterial applications

Liquid vaccines of live enveloped viruses

VIRUS LIKE PARTICLE PRODUCTION IN PLANTS

Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen

CORONAVIRUSES EPITOPE-BASED VACCINES

Betacoronavirus mRNA vaccine

Paramyxoviridae expression system

MERS-CoV vaccine

Compositions and methods for enhancing immune response to vaccination and improving vaccine production

Betacoronavirus mRNA vaccine

REDUCED FOAMING VACCINE COMPOSITIONS

APPLICATION OF PLANT AS HOST IN EXPRESSING VACCINE OF MIDDLE EAST RESPIRATORY SYNDROME

VACCINE ADJUVANT COMPOSITION BASED ON AMPHIPHILIC POLYAMINO ACID POLYMER, CONTAINING SQUALENE

H52 IBV vaccine with heterologous spike protein

4/91 IBV vaccine with heterologous spike protein

Apparatus for releasably holding a socket

Intranasal vector vaccine against porcine epidemic diarrhea

Expression of PEDV sequences in plants and plant produced vaccine for same

Prefusion coronavirus spike proteins and their use

Chimeric molecules and uses thereof

Porcine coronavirus vaccines

Human Antibodies to Middle East Respiratory Syndrome - Coronavirus Spike Protein

Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens

Immunogenic composition for MERS coronavirus infection

Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use

HPIV3 RNA vaccines

Vaccine against infectious bronchitis

Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus

hMPV RNA vaccines

Production of viruses in avian eggs

Methods of making solid vaccine compositions having reduced foaming

Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery

Multivalent vaccines for rabies virus and coronaviruses

Recombinant spike ectodomain proteins, compositions, vectors, kits, and methods for immunizing against avian infectious bronchitis virus

Attenuated infectious bronchitis virus

MERS-CoV vaccine

Adjuvant compositions

POULTRY VIRUS VACCINES THAT ARE LIQUID STABLE

Reduced foaming vaccine compositions

Vaccine composition and preparation method and use thereof

Production of viruses in avian eggs

Coronaviruses epitope-based vaccines

Coronaviruses, vaccines comprising the same, and methods for preventing disease

PORCINE EPIDEMIC DIARRHEA VIRUS VACCINES AND METHODS OF USE THEREOF

Combination PIV3/hMPV RNA vaccines

NSP10 self-assembling fusion proteins for vaccines, therapeutics, diagnostics and other nanomaterial applications

Viral vaccines and methods of forming the same

Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use

Live attenuated Arkansas serotype infectious bronchitis virus vaccine

Porcine epidemic diarrhea virus vaccine

POULTRY VIRUS VACCINES THAT ARE LIQUID STABLE

Whole expressed cell as antigen carrier, and use thereof in preparing vaccine or diagnostic agent, and screening monoclonal antibodies

IBV strains and uses thereof

Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom

Adaptation of attenuated infectious bronchitis virus (IBV) to embryonic kidney cells and vaccine thereby produced

Immunogenicity of an optimized synthetic consensus DNA vaccine for porcine epidemic diarrhea virus

Vaccine against infectious bronchitis virus

COMPOSITION COMPRISING PEDV ANTIGENS AND METHODS FOR MAKING AND USING THE COMPOSITION

Human antibodies to Middle East Respiratory Syndrome—coronavirus spike protein

Adjuvant compositions

Vaccine for use in protecting a pig against porcine epidemic diarrhea virus

Vaccine for Use in Protecting Offspring of a Sow Against Porcine Endemic Diarrhea Virus

LPS vaccine

Attenuated bovine coronavirus and related vaccines

Emulsified vaccine to obtain formulations of concentrated IgY immunoglobulins; processes and uses for the same

MERS-CoV vaccine

Coronavirus

VACCINE DELIVERY METHOD

Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus

IBV strains and uses thereof

Methods and compositions for chimeric coronavirus spike proteins

Porcine epidemic diarrhea virus vaccines and methods of use thereof

Swine virus vaccines that are liquid stable

Oral virus vaccine

Poultry virus vaccines that are liquid stable

Coronavirus proteins and antigens

Baculovirus display vectors and uses thereof

Immunogenic composition for MERS coronavirus infection

Reduced foaming vaccine compositions